Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Glia ; 58(1): 29-42, 2010 Jan 01.
Article in English | MEDLINE | ID: mdl-19455714

ABSTRACT

Axons are linked to induction of myelination during development and to the maintenance of myelin and myelinated tracts in the adult CNS. Currently, it is unknown whether and how axonal plasticity in adult CNS impacts the myelinating cells and their precursors. In this article, we report that newly formed axonal sprouts are able to induce a protracted myelination response in adult CNS. We show that newly formed axonal sprouts, induced by lesion of the entorhino-hippocampal perforant pathway, have the ability to induce a myelination response in stratum radiatum and lucidum CA3. The lesion resulted in significant recruitment of newly formed myelinating cells, documented by incorporation of the proliferation marker bromodeoxyuridine into chondroitin sulphate NG2 expressing cells in stratum radiatum and lucidum CA3 early after lesion, and the occurrence of a 28% increase in the number of oligodendrocytes, of which some had incorporated bromodeoxyuridine, 9 weeks post-lesion. Additionally, a marked increase (41%) in myelinated fibres was detected in silver stained sections. Interestingly, these apparently new fibres achieved the same axon diameter as unlesioned mice but myelin thickness remained thinner than normal, suggesting that the sprouting axons in stratum radiatum and lucidum CA3 were not fully myelinated 9 weeks after lesion. Our combined results show that sprouting axons provide a strong stimulus to oligodendrocyte lineage cells to engage actively in the myelination processes in the adult CNS.


Subject(s)
Axons/physiology , Myelin Sheath/metabolism , Nerve Fibers, Myelinated/metabolism , Neuronal Plasticity/physiology , Oligodendroglia/metabolism , Animals , Antigens/metabolism , Axons/ultrastructure , Axotomy/methods , CD11b Antigen/metabolism , Female , Hippocampus/injuries , Hippocampus/metabolism , Hippocampus/pathology , Hippocampus/ultrastructure , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Electron, Transmission/methods , Myelin Basic Protein/genetics , Myelin Sheath/ultrastructure , Nerve Fibers, Myelinated/ultrastructure , Nerve Regeneration/genetics , Neuronal Plasticity/genetics , Oligodendroglia/ultrastructure , Perforant Pathway/injuries , Perforant Pathway/metabolism , Proteoglycans/metabolism , Silver Staining/methods , Statistics, Nonparametric , beta-Galactosidase/genetics , beta-Galactosidase/metabolism
2.
J Neurosci ; 26(37): 9448-61, 2006 Sep 13.
Article in English | MEDLINE | ID: mdl-16971529

ABSTRACT

3,4-Dihydroxyphenyl-L-alanine (L-DOPA)-induced dyskinesia is associated with molecular and synaptic plasticity in the basal ganglia, but the occurrence of structural remodeling through cell genesis has not been explored. In this study, rats with 6-hydroxydopamine lesions received injections of the thymidine analog 5-bromo-2'-deoxyuridine (BrdU) concomitantly with L-DOPA for 2 weeks. A large number of BrdU-positive cells were found in the striatum and its output structures (globus pallidus, entopeduncular nucleus, and substantia nigra pars reticulata) in L-DOPA-treated rats that had developed dyskinesia. The vast majority (60-80%) of the newborn cells stained positively for endothelial markers. This endothelial proliferation was associated with an upregulation of immature endothelial markers (nestin) and a downregulation of endothelial barrier antigen on blood vessel walls. In addition, dyskinetic rats exhibited a significant increase in total blood vessel length and a visible extravasation of serum albumin in the two structures in which endothelial proliferation was most pronounced (substantia nigra pars reticulata and entopeduncular nucleus). The present study provides the first evidence of angiogenesis and blood-brain barrier dysfunction in an experimental model of L-DOPA-induced dyskinesia. These microvascular changes are likely to affect the kinetics of L-DOPA entry into the brain, favoring the occurrence of motor complications.


Subject(s)
Basal Ganglia/drug effects , Blood-Brain Barrier/drug effects , Dyskinesia, Drug-Induced/physiopathology , Endothelial Cells/drug effects , Levodopa/toxicity , Neovascularization, Pathologic/chemically induced , Animals , Antibodies, Monoclonal , Antigens/metabolism , Basal Ganglia/pathology , Basal Ganglia/physiopathology , Biomarkers/metabolism , Blood-Brain Barrier/physiopathology , Bromodeoxyuridine , Cell Count , Cell Proliferation/drug effects , Disease Models, Animal , Dopamine Agents/toxicity , Dyskinesia, Drug-Induced/metabolism , Endothelial Cells/pathology , Female , Intermediate Filament Proteins/metabolism , Motor Activity/drug effects , Motor Activity/physiology , Neovascularization, Pathologic/physiopathology , Nerve Tissue Proteins/metabolism , Nestin , Oxidopamine , Parkinsonian Disorders/drug therapy , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Proteoglycans/metabolism , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...